Bolstered by the generous support of donors, Weill Cornell Medicine has experienced dramatic growth in its research enterprise over the past five years – an achievement that advances the institution’s goal of providing patients with the most advanced treatments and therapies.
For many medical students, scholarships are key to making their education possible, and Weill Cornell Medicine is grateful for our donors who ensure that these students can confidently pursue their aspirations.
As new director of the Helen and Robert Appel Alzheimer’s Disease Research Institute, Dr. Li Gan is committed to making a transformational impact on patient care.
With a $7.5 million gift from the Friedman Family Foundation, endowed by Stephen and Vice Chair Overseer Barbara Friedman, Weill Cornell Medicine has established an innovative cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.
Weill Cornell Medicine is among the top-ranked clinical and medical research centers in the country, providing the best possible medical care to our patients, educating the health care leaders of tomorrow and speeding breakthrough discoveries from the lab bench to the patient bedside. At our core is a vision of physician-scientists working together, across disciplines, to accomplish these goals and continue providing world-class care to our patients, who are at the heart of our every endeavor.
With the recent opening of the state-of-the-art Belfer Research Building, we are positioned to greatly expand and accelerate our research program, bringing even more leading lights to our campus. We know that we are the right place and that this is the right time for Weill Cornell Medicine to be at the center of a transformation in medicine.
Weill Cornell Medicine continues to build on its track record of unprecedented growth. With a leading team of physician-scientists and the newest technology at our fingertips, we are perfectly poised to usher in a new era of personalized and 'tailored' medicine at our institution. We remain committed to keeping our students on the frontlines of medicine, and providing our faculty with the best opportunities and resources possible. As we look toward the future, there are myriad opportunities on the horizon.
Donors are the cornerstone of our work at Weill Cornell Medicine, helping us
lead the way in innovative treatments and pioneering research, pairing
medical education and the latest in technologies with a commitment to
compassionate and person-to-person care.
You are the agents of change in
advancing medicine and patient care.
— Jessica M. Bibliowicz
Chairman of the Board of Overseers, Weill Cornell Medicine